And pirfenidone treatment significantly inhibits liver fibrosis by inducing Glrx expression in HSCs by a Stat5‐dependent manner, which strongly addressed the key role of Glrx in liver fibrosis.49 Here, GLRX is linked to Hepatic fibrosis.